Vifor Pharma offers to fix alleged anti-competitive behaviour

 Vifor Pharma has offered to launch a marketing campaign to address any damage caused by its criticisms of a rival to its key drug, EU regulators said on Friday, a move that could stave off a potential fine and end an antitrust investigation.